Fundraising Fox

Verve Therapeutics

Cambridge, US · Founded 2018 · Delaware corporation · 5 known investors

vervetx.com ↗
Biotech

Founders & leadership

AA
Andrew AsheExecutive Officer
BA
Burt AdelmanDirector
JE
John EvansDirector
SK
Sekar KathiresanExecutive Officer, Director
AP
Anthony PhilippakisDirector
KY
Krishna YeshwantDirector
AB
Andrew BellingerExecutive Officer

Investors · 5

ARCH Venture PartnersChicago · $50K – $250M
F-Prime Capital PartnersCambridge · $3M – $10M
GV (Google Ventures)Mountain View · $250K – $50Mvia Anthony Philippakis · led
RA CapitalBoston
venBio PartnersSan Francisco

Reported raises · per SEC filings

Form D private placements
▶$94MraisedJan 2021 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew AsheExecutive Officer
  • Burt AdelmanDirector
  • John EvansDirector
  • Sekar KathiresanExecutive Officer, Director
  • Anthony PhilippakisDirector
  • Krishna YeshwantDirector
  • Andrew BellingerExecutive Officer
Offering amount
$94M
Amount sold
$94M
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.